Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label, Non-inferiority Study to Compare the Safety and Efficacy of BOR15001L7 to Docosanol 10% in Patients With Recurrent Herpes Labialis

NCT03977792 is registered in ClinicalTrials.gov with Laboratoire Boreaderme Inc. as lead sponsor.

NCT NCT03977792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03977792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label, Non-inferiority Study to Compare the Safety and Efficacy of BOR15001L7 to Docosanol 10% in Patients With Recurrent Herpes Labialis
Lead sponsor
Laboratoire Boreaderme Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2020
Completion date
July 31, 2022
Enrollment
164 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent herpes labialis